Liothymed 25 mcg Driada Medical

Description

Liothymed 25 mcg Driada Medical — Manufactured to exacting pharmaceutical standards, this pharmaceutical-grade thermogenic compound accelerates fat metabolism and supports lean body composition during cutting phases. Enhances metabolic rate while preserving lean muscle tissue. This formulation is dosed at 25 mcg per unit.

Key Benefits

• Synthetic thyroid hormone — overrides metabolic rate
• Pair with testosterone to prevent muscle catabolism
• Taper up from 25 mcg, taper down at cycle end
• Monitor TSH, free T3/T4 before and during
• Aggressive fat-burner — harsh on cardiovascular system
• Each unit dosed at 25 mcg — see Recommended Dosage below for protocol-specific intake

How It Works

Liothyronine, synthetic triiodothyronine (T3). Exogenous T3 suppresses TSH and shuts down endogenous thyroid output — taper critical to avoid hypothyroid rebound. Aggressively raises metabolic rate; catabolic to muscle without anabolic support.

Pharmacokinetics

Plasma half-life approximately 1–2 days. Once-daily dosing. Steady-state in 7 days. Endogenous thyroid suppression develops within a week.

Potential Side Effects

Tachycardia, sweating, insomnia, irritability. Muscle catabolism without anabolic support. TSH crashes — TFTs before starting, during, and 4 weeks after. Cardiovascular stress significant.

Cycle & Stacking Guide

6–8 weeks within an aggressive cut, always with testosterone base (150–200 mg/week minimum) to prevent muscle loss. Stack with clenbuterol for synergy. Not a standalone fat-burner.

Manufacturer Notes

Driada Medical positions itself at the affordable end of the market while maintaining third-party lab verification. Their vial caps carry a tamper-seal date code; batch COAs available through the distributor.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.